{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:15:49Z","timestamp":1780758949467,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":143,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jnci.2012.12.003","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T05:24:57Z","timestamp":1361510697000},"page":"37-41","source":"Crossref","is-referenced-by-count":11,"title":["The KRAS StripAssay for detection of KRAS mutation in Egyptian patients with colorectal cancer (CRC): A pilot study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yasser","family":"Abd El Kader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Emera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezzat","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neemat M.","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jnci.2012.12.003_b0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/1471-2407-11-406","article-title":"Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing","volume":"11","author":"Borr\u00e0s","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jnci.2012.12.003_b0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ctrv.2008.11.005","article-title":"Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR","volume":"35","author":"Heinemann","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jnci.2012.12.003_b0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605959","article-title":"KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis","volume":"103","author":"Deschoolmeester","year":"2010","journal-title":"Br J Cancer"},{"issue":"14","key":"10.1016\/j.jnci.2012.12.003_b0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jnci.2012.12.003_b0025","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gut.2005.066514","article-title":"The prognostic significance of K-ras, p53 and APC mutations in colorectal carcinoma","volume":"54","author":"Conlin","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jnci.2012.12.003_b0030","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2012.12.003_b0035","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jnci.2012.12.003_b0040","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.2009.21.9170","article-title":"American society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy","volume":"27","author":"Allegra","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2012.12.003_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8722-2-9","article-title":"Updates in gastrointestinal oncology\u2014insights from the 2008 44th annual meeting of the American society of clinical oncology","volume":"2","author":"Javle","year":"2009","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jnci.2012.12.003_b0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00428-008-0665-y","article-title":"KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program","volume":"453","author":"Van Krieken","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jnci.2012.12.003_b0055","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P","article-title":"Genetic alterations in the adenoma\u2013carcinoma sequence","volume":"70","author":"Cho","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jnci.2012.12.003_b0060","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/1078-0432.CCR-09-2446","article-title":"Prevalence and heterogeneity of KRAS, BRAF and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases","volume":"16","author":"Baldus","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jnci.2012.12.003_b0065","first-page":"2","article-title":"SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics","volume":"13","author":"Sarasqueta","year":"2011","journal-title":"JMD"},{"key":"10.1016\/j.jnci.2012.12.003_b0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/jcp.2008.063677","article-title":"Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis","volume":"62","author":"Ma","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jnci.2012.12.003_b0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1525-1578(10)60571-5","article-title":"Sensitive sequencing method for KRAS mutation detection by pyrosequencing","volume":"7","author":"Ogino","year":"2005","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jnci.2012.12.003_b0080","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.bjc.6603685","article-title":"Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy","volume":"96","author":"Di Fiore","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jnci.2012.12.003_b0085","doi-asserted-by":"crossref","first-page":"e7746","DOI":"10.1371\/journal.pone.0007746","article-title":"Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics","volume":"4","author":"Kotoula","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jnci.2012.12.003_b0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2353\/jmoldx.2009.090022","article-title":"Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization","volume":"11","author":"Ausch","year":"2009","journal-title":"J Mol Diagn"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036213000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036213000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T13:39:32Z","timestamp":1558618772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110036213000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1110036213000022"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2012.12.003","relation":{},"ISSN":["1110-0362"],"issn-type":[{"value":"1110-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}